USPTO serial 99435390
LIFE UNLOCKED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 21, 2026
- Examiner
- DIBLE, JONATHON I
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIFE UNLOCKED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kiranjit K Dharsan
Kiranjit K Dharsan Seiter IP1110 N Virgil Ave, Suite #98436Los Angeles, CA 90029United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for accessing information in the field of medicine and pharmaceutical research and development; Downloadable communication software for connecting users of laboratory computer networks and users of computer networks in diagnostic and pharmaceutical companies; Downloadable computer software for data analysis in the field of pharmaceutical research and development; Downloadable computer software for accessing information in the field of business networking and for management of electronic data, namely, digital multimedia content; Downloadable computer software for management of electronic data, namely, digital multimedia content | ACTIVE | — |
| 035 | Provision of business information and business management services to laboratory networks and diagnostic and pharmaceutical companies; Compilation of information, statistics, and data relating to medicine and pharmaceutical testing, research, and development, for business purposes; Business data analysis | ACTIVE | — |
| 041 | Education services, namely, training services in the field of development of pharmaceutical preparations and medicines; Education services, namely, training services in the field of analysis of medical testing data; Online education services, namely, providing online training programs in the field of communication between laboratory networks and diagnostic and pharmaceutical companies | ACTIVE | — |
| 042 | Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Research relating to medicines; Testing of pharmaceuticals; Design and development of medical diagnostic apparatus; Research and development in the field of diagnostic preparations; Design and development of computer databases; Design services relating to software, namely, data processing test tools; Provision of information relating to medical and veterinary research and development; Hosting of databases in the nature of server hosting; Providing temporary use of online non-downloadable web-based software applications for connecting users of laboratory computer networks and users of computer networks in diagnostic and pharmaceutical companies; Non-downloadable software as a service (SAAS) services featuring software for data management, data analysis, and data manipulation in the field of medicine and pharmaceutical testing, research, and development; Non-downloadable software as a service (SAAS) services featuring communication software for connecting users of laboratory computer networks and users of computer networks in diagnostic and pharmaceutical companies; Non-downloadable software as a service (SAAS) services featuring software for management of electronic data, namely, digital multimedia content, and for enabling users to access online training in the field of pharmaceutical research and development; Non-downloadable software as a service (SAAS) services featuring software in the field of pharmaceutical research and development for managing electronic data and for data visualization, namely, for generating reports, charts, and dashboards being digital user interfaces; Non-downloadable platform as a service (PAAS) services featuring software platforms for data management, data analysis, and data manipulation in the field of medicine and pharmaceutical testing, research, and development; Non-downloadable platform as a service (PAAS) services featuring software platforms for connecting users of laboratory computer networks and users of computer networks in diagnostic and pharmaceutical companies; Non-downloadable platform as a service (PAAS) services featuring software platforms for management of electronic data, namely, digital multimedia content, and for enabling users to access online training in the field of pharmaceutical research and development; Non-downloadable platform as a service (PAAS) services featuring software platforms in the field of pharmaceutical research and development for managing electronic data and for data visualization, namely, for generating reports, charts, and dashboards being digital user interfaces; Information, advice and consultancy in relation to all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Diaceutics Plc
- Other trademarks owned by Diaceutics Plc
- Other trademarks owned by Diaceutics Plc
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named LIFE UNLOCKED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 21, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2025 | NWAP | NEW APPLICATION ENTERED | — |